272 related articles for article (PubMed ID: 15481316)
1. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.
Hanai H; Takeuchi K; Iida T; Kashiwagi N; Saniabadi AR; Matsushita I; Sato Y; Kasuga N; Nakamura T
Dig Dis Sci; 2004 Sep; 49(9):1438-43. PubMed ID: 15481316
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
[TBL] [Abstract][Full Text] [Related]
3. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
[TBL] [Abstract][Full Text] [Related]
4. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
Xiang JY; Ouyang Q; Li GD; Xiao NP
World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
[TBL] [Abstract][Full Text] [Related]
7. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Renzulli P; Seibold F
Inflamm Bowel Dis; 2009 Dec; 15(12):1851-8. PubMed ID: 19462421
[TBL] [Abstract][Full Text] [Related]
9. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.
Amati L; Passeri ME; Selicato F; Mastronardi ML; Penna A; Jirillo E; Covelli V
Immunopharmacol Immunotoxicol; 2006; 28(4):665-81. PubMed ID: 17190742
[TBL] [Abstract][Full Text] [Related]
10. Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.
Voiosu T; Benguş A; Bălănescu P; Dinu R; Voiosu A; Băicuş C; Mateescu B
Rom J Intern Med; 2015; 53(3):253-60. PubMed ID: 26710501
[TBL] [Abstract][Full Text] [Related]
11. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
13. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
14. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
15. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
Fukunaga S; Kuwaki K; Mitsuyama K; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Mori A; Kakuma T; Tsuruta O; Torimura T
Int J Mol Med; 2018 Jan; 41(1):107-118. PubMed ID: 29115397
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
17. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
18. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.
Burri E; Beglinger C; von Felten S; Lehmann FS
Dig Dis Sci; 2015 Feb; 60(2):485-91. PubMed ID: 25344905
[TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
